This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.


Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


Tutorial:Basic Chemistry Topics

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 12: Line 12:
=='''Summary: Scientific Research Artical'''==
=='''Summary: Scientific Research Artical'''==
-
*The study where this molecule was obtained is named "Aminoglycoside 2'-N-acetyltransferase from Mycobacterium tuberculosis-Complex with Coenzyme A and Tobramycin". The study focused on AAC (2’)- Ic, also known as aminoglycoside 2’- N- acetyltransferase. The scientists in the study determined the crystal structure of AAC (2’)-Ic from Mycobacterium tuberculosis. The specific fold of AAC (2’)-Ic is placed in the GNAT or GCN5-related N-acetyltransferase superfamily. Although the physiological function of AAC(2’)-Ic is not certain, the crystal structure determined by the scientists allowed them to hypothesize. Through the crystal structure, scientists determined that this enzyme might acetylate mycothiol, which is a key biosynthetic intermediate and the major reducing agent in mycobacterium. This enzyme is capable of acetylating aminoglycosides bearing a 2’ amino group. When this occurs the aminoglycoside antibiotic becomes inactive.
+
*The study where this molecule was obtained is named "Aminoglycoside 2'-N-acetyltransferase from Mycobacterium tuberculosis-Complex with Coenzyme A and Tobramycin". The study focused on AAC (2’)- Ic, also known as aminoglycoside 2’- N- acetyltransferase. The scientists in the study determined the crystal structure of AAC (2’)-Ic from Mycobacterium tuberculosis. The specific fold of AAC (2’)-Ic is placed in the GNAT or GCN5-related N-acetyltransferase superfamily. Although the physiological function of AAC(2’)-Ic is not certain, the crystal structure determined by the scientists allowed them to hypothesize. Through the crystal structure, scientists determined that this enzyme might acetylate mycothiol, which is a key biosynthetic intermediate and the major reducing agent in mycobacterium. This enzyme is capable of acetylating aminoglycosides bearing a 2’ amino group. When this occurs the aminoglycoside antibiotic becomes inactive.<references name="1"/>

Revision as of 23:06, 31 October 2012

Structure of HMG-CoA reductase (PDB entry 1dq8)

Drag the structure with the mouse to rotate

References

Proteopedia Page Contributors and Editors (what is this?)

Alyssa Graham

Personal tools